Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$50.90 USD
+0.80 (1.60%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $50.83 -0.07 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC7/24/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 3.70% |
ABR | 1.00 |
Earnings ESP
|
-26.38% |
---|---|
Current Year | -1.11 |
Next Year | -1.45 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.28 | -1.11 | -1.45 |
# of Estimates | 9 | 9 | 9 | 8 |
Most Recent Consensus | -0.23 | -0.26 | -1.04 | -2.05 |
High Estimate | -0.17 | -0.20 | -0.85 | -0.96 |
Low Estimate | -0.33 | -0.35 | -1.33 | -2.05 |
Year ago EPS | -0.19 | -0.23 | -0.91 | -1.11 |
Year over Year Growth Est. | -36.84% | -21.74% | -21.98% | -30.76% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.28 | -1.11 | -1.45 |
7 Days Ago | -0.26 | -0.28 | -1.11 | -1.45 |
30 Days Ago | -0.25 | -0.27 | -1.08 | -1.42 |
60 Days Ago | -0.25 | -0.27 | -1.08 | -1.42 |
90 Days Ago | -0.27 | -0.28 | -1.10 | -1.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.33 | -0.35 | -1.33 | -1.71 |
Zacks Consensus Estimate | -0.26 | -0.28 | -1.11 | -1.45 |
Earnings ESP | -26.38% | -25.50% | -19.70% | -17.73% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.25 | -0.23 | -0.19 | NA |
Estimate | -0.27 | -0.25 | -0.22 | -0.21 | NA |
Difference | 0.01 | 0.00 | -0.01 | 0.02 | 0.01 |
Surprise | 3.70% | 0.00% | -4.55% | 9.52% | 2.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more